First National Bank of Omaha’s Idexx Laboratories IDXX Stock Holding History

First National Bank of Omaha’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-336	Closed	-$221K	–	346
2021 Q4	$221K	Sell	336 -146	-30%	-$91.7K	0.01%	333
2021 Q3	$300K	Sell	482 -5	-1%	-$3.36K	0.02%	312
2021 Q2	$238K	Hold	487	–	–	0.01%	334
2021 Q1	$238K	Sell	487 -55	-10%	-$27.6K	0.01%	334
2020 Q4	$271K	Buy	+542	New	+$243K	0.01%	327

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

First National Bank of Omaha's IDXX Position: Q1 2022 in Review

First National Bank of Omaha sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 336 shares — an estimated $221K sold.

First National Bank of Omaha first reported a position in IDXX in Q4 2020 and held it in 5 quarters. The position peaked at $300K in Q3 2021. 1,033 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

First National Bank of Omaha reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
First National Bank of Omaha sold 336 Idexx Laboratories shares in Q1 2022, an estimated $221K.
First National Bank of Omaha first reported a position in Idexx Laboratories in Q4 2020 and held it in 5 quarters.
First National Bank of Omaha's Idexx Laboratories position peaked at $300K in Q3 2021.
1,033 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on First National Bank of Omaha's 13F filing for Q1 2022, filed 25 May 2022.